ScoreWhy is ApicHope Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -12.52% and Operating profit at -210.75% over the last 5 years
2
Flat results in Mar 26
- NET SALES(HY) At CNY 503.74 MM has Grown at -14.24%
- DEBTORS TURNOVER RATIO(HY) Lowest at 2.23 times
- INTEREST(Q) At CNY 15.89 MM has Grown at 12.54%
3
With ROE of 11.51%, it has a very expensive valuation with a 7.58 Price to Book Value
- Over the past year, while the stock has generated a return of -26.53%, its profits have risen by 137% ; the PEG ratio of the company is 0.5
- At the current price, the company has a high dividend yield of 0
4
Underperformed the market in the last 1 year
- Even though the market (China Shanghai Composite) has generated returns of 16.83% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -26.53% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is ApicHope Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
ApicHope Pharmaceutical Co., Ltd.
-41.75%
1.17
71.80%
China Shanghai Composite
3.0%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-12.52%
EBIT Growth (5y)
-210.75%
EBIT to Interest (avg)
1.18
Debt to EBITDA (avg)
1.47
Net Debt to Equity (avg)
0.87
Sales to Capital Employed (avg)
0.42
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.90%
ROE (avg)
9.84%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
66
Industry P/E
Price to Book Value
7.59
EV to EBIT
-47.69
EV to EBITDA
-101.68
EV to Capital Employed
5.87
EV to Sales
16.33
PEG Ratio
0.48
Dividend Yield
NA
ROCE (Latest)
-12.31%
ROE (Latest)
11.51%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend16What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 649.11 MM
NET PROFIT(HY)
Higher at CNY 484.72 MM
ROCE(HY)
Highest at 12.05%
CASH AND EQV(HY)
Highest at CNY 2,647.09 MM
-19What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.08 times
RAW MATERIAL COST(Y)
Grown by 90.77% (YoY
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.88 times
NET SALES(Q)
Lowest at CNY 106.25 MM
PRE-TAX PROFIT(Q)
Lowest at CNY -718.91 MM
Here's what is working for ApicHope Pharmaceutical Co., Ltd.
Net Profit
At CNY 484.72 MM has Grown at 759.11%
Year on Year (YoY)MOJO Watch
Net Profit trend is very positive
Net Profit (CNY MM)
Net Profit
Higher at CNY 484.72 MM
than preceding 12 month period ended Jun 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (CNY MM)
Operating Cash Flow
Highest at CNY 649.11 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Cash and Eqv
Highest at CNY 2,647.09 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for ApicHope Pharmaceutical Co., Ltd.
Net Sales
At CNY 106.25 MM has Fallen at -48.63%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Pre-Tax Profit
At CNY -718.91 MM has Fallen at -355.71%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Debtors Turnover Ratio
Lowest at 2.08 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Net Sales
Lowest at CNY 106.25 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Pre-Tax Profit
Lowest at CNY -718.91 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Inventory Turnover Ratio
Lowest at 1.88 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Raw Material Cost
Grown by 90.77% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
